Literature DB >> 2221667

Caldesmon: fragments, sequence, and domain mapping.

J Bryan1.   

Abstract

A summary of the available binding site data is shown in Figure 6 and should be compared with the predicted structures in Figure 5. The blocks of amino acid sequence were those known at the time the cDNA sequencing was being done; they now include the entire head region. The phosphorylation site, indicated here, is a potential site, a consensus sequence, -AXYS(T)-, for the multifunctional calmodulin-dependent kinase. It has not been established that this site is utilized, and it is not clearly related to any of the established binding domains. Exactly how caldesmon regulates the actomyosin interaction and whether it contributes to the latch state is unclear. The organization of the molecule suggests, however, that it could function as a bridge between thick and thin filaments. In support of this idea, our recent efforts to map the smaller non-muscle form of caldesmon indicate that it retains the myosin and the calmodulin approximately actin binding domains, but is missing the central repeated region, arguing this region may serve to space the N and C terminal-binding domains in smooth muscle. Work from several laboratories has demonstrated that smooth muscle caldesmon is an elongated molecule with a calmodulin, tropomyosin, and actin-binding region at the C-terminus and a myosin-binding domain at the N-terminus. Sequence determination has shown that smooth muscle caldesmon is smaller than previously believed, has demonstrated similarities between caldesmon and troponin T, and has suggested possible calmodulin-binding peptides. The available sequence and domain mapping studies on smooth muscle caldesmon are reviewed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221667     DOI: 10.1111/j.1749-6632.1990.tb42368.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Sequence of an avian non-muscle caldesmon.

Authors:  J Bryan; R Lee
Journal:  J Muscle Res Cell Motil       Date:  1991-08       Impact factor: 2.698

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system.

Authors:  Z Wang; K Y Horiuchi; S S Jacob; S Gopalakurup; S Chacko
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

4.  Studies on secondary structure of caldesmon and its C-terminal fragments.

Authors:  E A Czuryło; R Dabrowska
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

5.  Amino acid mutations in the caldesmon COOH-terminal functional domain increase force generation in bladder smooth muscle.

Authors:  Maoxian Deng; Ettickan Boopathi; Joseph A Hypolite; Tobias Raabe; Shaohua Chang; Stephen Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

6.  Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature.

Authors:  Ping-Pin Zheng; Anieta M Sieuwerts; Theo M Luider; M van der Weiden; Peter A E Sillevis-Smitt; Johan M Kros
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

7.  Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.

Authors:  Samuel Rivero-Hinojosa; Ling San Lau; Mojca Stampar; Jerome Staal; Huizhen Zhang; Heather Gordish-Dressman; Paul A Northcott; Stefan M Pfister; Michael D Taylor; Kristy J Brown; Brian R Rood
Journal:  Acta Neuropathol Commun       Date:  2018-06-07       Impact factor: 7.801

8.  Ageing causes an aortic contractile dysfunction phenotype by targeting the expression of members of the extracellular signal-regulated kinase pathway.

Authors:  Christopher J Nicholson; Yi Xing; Sophie Lee; Stephanie Liang; Shivani Mohan; Caitlin O'Rourke; Joshua Kang; Kathleen G Morgan
Journal:  J Cell Mol Med       Date:  2022-02-18       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.